Fatigue as Mediator Factor in PTSD-Symptoms after Allogeneic Hematopoietic Stem Cell Transplantation

Background: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) is a valid treatment for hematological oncological or metabolic diseases. Despite its therapeutic efficacy, it is an aggressive treatment that impacts negatively on quality of life (QoL) and may result in Post-Traumatic Stress Dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Francesco, Giulia, Cieri, Filippo, Esposito, Roberto, Sciarra, Pierpaola, Ballarini, Valeria, Di Ianni, Mauro, Santarone, Stella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144210/
https://www.ncbi.nlm.nih.gov/pubmed/37109093
http://dx.doi.org/10.3390/jcm12082756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144210/
https://www.ncbi.nlm.nih.gov/pubmed/37109093
http://dx.doi.org/10.3390/jcm12082756

Ejemplares similares